It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Today’s mass-produced tomatoes often grow to palm-sized proportions, but their naturally occurring ancestors were far smaller ...

Selection for bigger tomatoes has made the fruits less sweet, but now it has been shown that gene editing can make them ...

Rotten tomatoes no more: growing sweeter tomatoes is possible by editing just two of the fruit’s genes. Deleting the genes ...

Life Sciences Center (LSC) have discovered a unique way for cells to silence specific genes without cutting DNA. This ...

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

Disease markers stabilized or improved in cardiomyopathy patients who received a single dose of Intellia Therapeutics’ in ...

We recently compiled a list of the ARK Invest Stock Portfolio: Top 10 Stock Picks for 2024. In this article, we are going to ...

Analysts appear optimistic for Intellia’s gene editor nex-z, which showed a greater serum TTR reduction than Alnylam’s ...

Intellia Therapeutics CEO John Leonard has, for the last couple years, found himself stuck in a financial Groundhog Day.

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...